TREA

87826150 - PREDNISOLONE PO4 / GATIFLOXACIN / BROMFENAC SODIUM SESQUIHYDRATE OPHTHALMIC SOLUTION 1% / 0.5% / 0.07% SCIENCE OMNI BY OCULAR SCIENCE

Follow

Information

  • Trademark
  • 87826150
  • Serial Number
    87826150
  • Filing Date
    March 08, 2018
    6 years ago
  • Transaction Date
    January 07, 2020
    4 years ago
  • Status Date
    April 08, 2019
    5 years ago
  • Published for Opposition Date
    July 10, 2018
    6 years ago
  • Location Date
    September 04, 2018
    6 years ago
  • Status Code
    606
  • Current Location
    INTENT TO USE SECTION
    Employee Name
    PINO, BRIAN J
  • Attorney Name
    Eric Kelly
    Law Office Assigned Location Code
    M50
  • Owners
Information
Mark Drawing Code
3000
Mark Identification
PREDNISOLONE PO4 / GATIFLOXACIN / BROMFENAC SODIUM SESQUIHYDRATE OPHTHALMIC SOLUTION 1% / 0.5% / 0.07% SCIENCE OMNI BY OCULAR SCIENCE
Case File Statements
  • CC0000: Color is not claimed as a feature of the mark.
  • D10000: "PREDNISOLONE PO4 / GATIFLOXACIN / BROMFENAC SODIUM SESQUIHYDRATE OPHTHALMIC SOLUTION 1% / 0.5% / 0.07%" AND "BY OCULAR SCIENCE"
  • DM0000: The mark consists of the words "Prednisolone PO4 / Gatifloxacin / Bromfenac Sodium Sesquihydrate Ophthalmic Solution 1% / 0.5% / 0.07%" above the words of "OMNI by OCULAR SCIENCE". The "Prednisolone PO4 / Gatifloxacin / Bromfenac" words are above the "Sodium Sesquihydrate Ophthalmic Solution" words. The "Sodium Sesquihydrate Ophthalmic Solution" words are above the "1% / 0.5% / 0.07%" words. The "Prednisolone PO4 / Gatifloxacin / Bromfenac Sodium Sesquihydrate Ophthalmic Solution 1% / 0.5% / 0.07%" words are superimposed over a background of stripes. The word "OMNI" is above the words "by OCULAR SCIENCE". The words "by OCULAR SCIENCE" is centered with respect to "OMNI". The lettering for "OMNI" is larger than the lettering for "by OCULAR SCIENCE". There is a shaded circle behind most of the letter "M" in "OMNI". There is a top arc that begins between the "O" and the "M" of "OMNI" and arcs towards the right ending to the right of the "I" in "OMNI". There is a bottom arc that begins at the "N" in "OMNI" and then arcs towards the left ending to the left of the "O" in "OMNI".
  • GS0051: Ophthalmic preparations
  • PM0001: PREDNISOLONE PO FOUR / GATIFLOXACIN / BROMFENAC SODIUM SESQUIHYDRATE OPHTHALMIC SOLUTION ONE PERCENT / POINT FIVE PERCENT / POINT SEVEN PERCENT OMNI BY OCULAR SCIENCE
Case File Event Statements
  • 4/8/2019 - 5 years ago
    17 - ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED Type: MAB6
  • 4/8/2019 - 5 years ago
    16 - ABANDONMENT - NO USE STATEMENT FILED Type: ABN6
  • 9/4/2018 - 6 years ago
    15 - NOA E-MAILED - SOU REQUIRED FROM APPLICANT Type: NOAM
  • 7/10/2018 - 6 years ago
    14 - OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED Type: NPUB
  • 7/10/2018 - 6 years ago
    13 - PUBLISHED FOR OPPOSITION Type: PUBO
  • 6/20/2018 - 6 years ago
    12 - NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED Type: NONP
  • 6/2/2018 - 6 years ago
    11 - LAW OFFICE PUBLICATION REVIEW COMPLETED Type: PREV
  • 5/31/2018 - 6 years ago
    10 - ASSIGNED TO LIE Type: ALIE
  • 5/16/2018 - 6 years ago
    9 - APPROVED FOR PUB - PRINCIPAL REGISTER Type: CNSA
  • 5/16/2018 - 6 years ago
    8 - EXAMINER'S AMENDMENT ENTERED Type: XAEC
  • 5/16/2018 - 6 years ago
    7 - NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED Type: GNEN
  • 5/16/2018 - 6 years ago
    6 - EXAMINERS AMENDMENT E-MAILED Type: GNEA
  • 5/16/2018 - 6 years ago
    5 - EXAMINERS AMENDMENT -WRITTEN Type: CNEA
  • 5/10/2018 - 6 years ago
    4 - ASSIGNED TO EXAMINER Type: DOCK
  • 3/16/2018 - 6 years ago
    3 - NOTICE OF DESIGN SEARCH CODE E-MAILED Type: MDSM
  • 3/15/2018 - 6 years ago
    2 - NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM Type: NWOS
  • 3/12/2018 - 6 years ago
    1 - NEW APPLICATION ENTERED IN TRAM Type: NWAP